Head-to-head · Cost-Efficiency Index
Curex vs Vivanta Care
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Curex
People who want a low-cost first month, an oral option, and a verified pharmacy nationwide, and don't need a dose-by-dose price table before signing up.
Visit CurexVivanta Care
People starting a GLP-1 at a low dose who want a cheap first few months and can see what the higher doses will cost before they sign up.
Visit Vivanta CareThe verdict
Curex takes it, leading the Cost-Efficiency Index 81 to 80. A discounted first month ($49-$149) steps up to a 'starting at $199' ongoing rate — real, but not the flat, fully-disclosed price the headline implies, and California loses the injectable route entirely. Vivanta Care still earns a B− — People starting a GLP-1 at a low dose who want a cheap first few months and can see what the higher doses will cost before they sign up.
Worth knowing either way: CoreAge Rx is one of our partners and leads our leaderboard, where partners are listed first (Cost-Efficiency Index 94/100). See how it stacks up: CoreAge Rx vs Curex.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Curex | Vivanta Care |
|---|---|---|
| Cost-Efficiency Index | 81/100 | 80/100 |
| Semaglutide / mo | $199/moStarting (first month $49) | $79/moStarting dose; $169, $229 and $299 at higher dose stages, compounded |
| Tirzepatide / mo | $199/moStarting (first month $149) | $99/moStarting dose; $139, $249 and $329 at higher dose stages, compounded |
| Semaglutide / yr (modeled) | $2,388 | $948 |
| Tirzepatide / yr (modeled) | $2,388 | $1,188 |
| Coverage | All 50 states (California: oral tablet only, no injectable) | All 50 states and D.C. |
| Oral / sublingual | Yes | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #30 | #37 |
Curex
81/100Where the value is
- Discounted first month well below the ongoing rate — $49 for semaglutide, $149 for tirzepatide
- Nationwide enrollment (all 50 states) plus an oral/sublingual route as an alternative to injections
- 365-day money-back guarantee and a full refund if never prescribed
The tradeoffs
- The '$199/mo' figure is labeled 'Starting,' not flat, and no dose-by-dose price table is published, so ask what a higher maintenance dose costs
- California residents cannot get the injectable route at all — oral tablets only, despite the 'all 50 states' enrollment claim
Regulatory note: the FDA issued a warning letter to Curex in September 2025. We still list and link to Curex; you should know the letter is on the public record before you decide.
Vivanta Care
80/100Where the value is
- All four dose-stage prices for each drug appear on the first screen of its quiz, before you answer any health questions
- Each plan covers the medical visit, the medication and shipping, with no separate membership fee
- Names its pharmacy (DiRx in Fort Lauderdale) and its clinician network (MD Integrations)
The tradeoffs
- The $79 and $99 prices cover only the starting dose; at the higher stages semaglutide reaches $299 and tirzepatide $329
- Its FAQ says pricing "stays the same at every dose", which doesn't match the dose-stage prices in the quiz
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.